Legato Capital Management’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$703K Buy
19,529
+5,407
+38% +$195K 0.08% 371
2025
Q1
$557K Buy
14,122
+3,775
+36% +$149K 0.08% 406
2024
Q4
$311K Sell
10,347
-3,104
-23% -$93.4K 0.04% 492
2024
Q3
$315K Buy
+13,451
New +$315K 0.04% 506
2023
Q3
Sell
-10,710
Closed -$266K 642
2023
Q2
$266K Buy
+10,710
New +$266K 0.04% 491
2021
Q3
Sell
-19,348
Closed -$751K 309
2021
Q2
$751K Buy
+19,348
New +$751K 0.11% 199